Company intelligence / Profile preview

Phoenix Strategy

Des Moines, Iowa, United Statesphoenixstrategy.group ↗

Ownership: Private
Development stage: Other

Overview

Phoenix Biotechnology is focused on developing therapies for the prevention and treatment of malignant diseases. The company’s Chief Science Officer has an extensive track record in preclinical and clinical pharmacology, toxicology, and drug development for cancer. No specific clinical results or lead program data are publicly available.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Phoenix Strategy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phoenix Strategy.

Explore the full profile